---
title: "Dawnrays Pharma hits 52-week low"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306232307.md"
description: "Dawnrays Pharma fell 1.70% to HK$0.8650. Down 4.95% over ten sessions and down 25.24% YTD."
datetime: "2026-11-20T07:08:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306232307.md)
  - [en](https://longbridge.com/en/news/306232307.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306232307.md)
generator: "portal-rs"
---

# Dawnrays Pharma hits 52-week low

Dawnrays Pharma (2348.HK) slipped nearly **2%** in Hong Kong trading to **HK$0.8650**, hitting a 52-week low intraday.

The stock is down 4.95% over the past ten sessions and down 25.24% year to date. It sits 27.13% below its 52-week high of HK$1.187. Volume was 6.11 times its average.

The Hang Seng Index is down 5.46% over the past five sessions and down 12.81% year to date.

The pharmaceuticals industry index fell 4.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [02348.HK](https://longbridge.com/en/quote/02348.HK.md)

## Related News & Research

- [Dawnrays Pharmaceutical Discloses Share Buyback in HKEX Next-Day Return](https://longbridge.com/en/news/305794886.md)
- [Dawnrays Pharmaceutical Reports Share Buyback in HKEX Next Day Disclosure Return](https://longbridge.com/en/news/302536211.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)
- [AI tech rout prompts US investors to rush into value stocks](https://longbridge.com/en/news/306321872.md)
- [Key facts: SK hynix results surge; Kioxia stake rises; HYAICO formed](https://longbridge.com/en/news/306338337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**